Companies Dominating the Europe OTC Parasiticides Landscape
- Inovet
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- Chanelle Pharma
- Ceva Sante Animale
- Vetoquinol S.A.
- Boehringer Ingelheim International GmbH
- PetlQ, LLC.
- Syndel
- Elanco Animal Health Incorporated
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Increased demand for parasiticides, rising empathy for animals, and higher count of livestock are the few factors which is likely to boost the market growth.
The market is anticipated to attain a CAGR of 6.26% over the forecast period, i.e., 2022-2031.
Illegal selling of parasiticides and risk of parasiticides impacting human health and other invertebrates are the few factors that are to hamper the market growth.
The market in rest of Europe is projected to hold the largest market share of USD 180.1 million by the end of 2031 and provide more business opportunities in the future. The market in the region to grow at a CAGR of 5.59% over the forecast period. In 2021, the region garnered a revenue of USD 104.90 million.
The major players in the market are Inovet, Merck & Co., Inc., Chanelle Pharma, Ceva Sante Animale, Vetoquinol S.A., Boehringer Ingelheim International GmbH, PetlQ, LLC., Syndel, Elanco Animal Health Incorporated, and Others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product, animal, end user, distribution channel, and by country.
The dog segment is anticipated to garner the largest market size of USD 286.02 million by the end of 2031 and display significant growth opportunities. The segment is to grow at a CAGR of 6.47% over the forecast period. The segment garnered a revenue of USD 153.46 million in 2021.
